From: Predictors of early death in a cohort of Ethiopian patients treated with HAART
Factor | Crude HR (95%CI) | P-value | Adjusted HR (95%CI) | P-value |
---|---|---|---|---|
TLC <= 750 vs. >750/mcL | 3.6 (1.5–8.1) | 0.002 | 3.6 (1.4–9.6) | 0.009 |
WHO stage IV vs. II-III | 3.7 (1.6–8.5) | 0.002 | 2.7 (1.01–7.3) | 0.047 |
BMI <= 18.5 vs. >18.5 kg/m2 | 2.9 (1.04–8.0) | 0.042 | 2.7 (0.9–7.4) | 0.062 |
HGB <= 10 g/dl vs. >10 g/dl | 2.5 (0.8–7.4) | 0.094 | -- | -- |
TLC <= 1200 vs. >1200/mcL | 2.3 (0.8–6.8) | 0.130 | -- | -- |